COPENHAGEN, Denmark — In a significant move to accelerate the global transition toward sustainable manufacturing, Novonesis has officially been named a bluesign System Partner, a designation that reinforces the company’s commitment to advancing environmental and safety standards within the textile and leather industries. The announcement, made in May 2026, marks a pivotal alignment between one of the world’s leading biosolutions providers and the industry’s most rigorous sustainability auditing framework. By joining the bluesign System, Novonesis integrates its extensive portfolio of enzymatic and microbial technologies into a verified network that prioritizes chemical management, resource efficiency, and consumer safety.
The partnership comes at a time when the textile and leather sectors are under intense scrutiny from regulators, investors, and consumers to reduce their environmental footprint. As a bluesign System Partner, Novonesis commits to the "Input Stream Management" approach. This methodology shifts the focus from testing finished products to ensuring that the chemicals and processes used at the beginning of the manufacturing cycle meet strict ecological and toxicological criteria. This proactive stance is designed to eliminate hazardous substances before they ever enter the production hall, thereby protecting workers, local ecosystems, and the end consumer.
A Strategic Validation of Bio-Innovation
The induction of Novonesis into the bluesign network is viewed by industry analysts as a major validation of the company’s "Better Business with Biology" strategy. Since its formation through the high-profile merger of Novozymes and Chr. Hansen, Novonesis has positioned itself as a powerhouse in industrial biotechnology. The company’s vice president of global marketing for household and industrial biosolutions, Hans Ole Klingenberg, emphasized that this partnership is more than a certification; it is a testament to the transformative power of enzymes in replacing traditional, resource-heavy industrial chemistry.
"Becoming a bluesign System Partner is a strong validation of our approach to innovation," Klingenberg stated. "Our biosolutions are designed to help the textile and leather industries move away from resource-intensive and hazardous processes. This partnership reflects our commitment to engage with rigorous standards for environmental and chemical management across the textile and leather value chain."
The bluesign System is built on science-driven criteria and primary data verified by independent experts. It connects chemical suppliers, textile manufacturers, and global brands within a unified ecosystem. For Novonesis, this means its biology-based enzymatic solutions will now be part of the bluesign FINDER—a database used by manufacturers worldwide to source chemicals that are pre-approved for sustainable production.
Technical Milestones: The Impact of DeniBrite
Central to Novonesis’ contribution to the partnership is its suite of enzymatic solutions tailored for specific industrial challenges. A primary example is DeniBrite, a biological denim bleaching platform that has already begun to reshape the laundries of major garment hubs. Traditional denim bleaching relies heavily on harsh oxidizing agents, most notably sodium hypochlorite (chlorine) and potassium permanganate (KMnO4). These substances are not only environmentally damaging when discharged into waterways but also pose significant health risks to factory workers.
The DeniBrite platform utilizes laccases—enzymes that catalyze the oxidation of indigo dye using atmospheric oxygen as the oxidant. This biological process allows denim laundries to achieve the popular "distressed" or "vintage" look without the corrosive effects of traditional bleaches. According to internal data and field trials, switching to enzymatic bleaching can lead to a 30% to 50% reduction in water usage during the rinsing phase, as enzymes are more easily neutralized than persistent chemical bleaches. Furthermore, because enzymes operate at lower temperatures, the energy required for the bleaching bath is significantly reduced.
"Solutions like DeniBrite show the potential of biosolutions to transform traditional processes," Klingenberg added. "By replacing harsh chemicals with enzymes, manufacturers can improve worker safety, reduce chemical use, and lower their environmental footprint, helping them meet increasing regulatory, brand, and customer demands."
Contextual Background: The Evolution of Novonesis
To understand the weight of this partnership, it is essential to look at the recent history of Novonesis. The company emerged in early 2024 following the completion of the merger between Danish biotech giants Novozymes and Chr. Hansen. This merger created a global leader in biosolutions with an annual revenue exceeding €3.7 billion and a workforce of over 10,000 employees.
Prior to the merger, both companies had long-standing reputations for sustainability. Novozymes was a pioneer in industrial enzymes, while Chr. Hansen specialized in microbial and food cultures. The unified entity, Novonesis, has since focused on leveraging this combined expertise to tackle decarbonization and chemical reduction in sectors ranging from agriculture and food to household care and textiles. The bluesign partnership represents one of the first major industrial certifications for the textile division of the newly formed company, signaling a unified front in its approach to global sustainability standards.
The bluesign Framework: Five Pillars of Sustainability
The partnership requires Novonesis to adhere to the five pillars of the bluesign System, which provide a holistic framework for industrial responsibility:
- Resource Productivity: Optimizing the use of energy, water, and raw materials to minimize the environmental impact per unit of production.
- Consumer Safety: Ensuring that final textile products do not contain substances that are harmful to human health.
- Water Emission: Monitoring and reducing the discharge of pollutants into the water cycle through advanced wastewater treatment and cleaner input chemistry.
- Air Emission: Controlling the release of volatile organic compounds (VOCs) and greenhouse gases during the manufacturing process.
- Occupational Health and Safety: Protecting workers from exposure to hazardous chemicals and ensuring safe working conditions on the factory floor.
Barbara Oswald, Chief Commercial Officer at bluesign, welcomed Novonesis, noting the importance of enzyme-based technologies in the industry’s "green" transition. "Their focus on biosolutions supports the industry’s transition toward safer and more responsible production processes across textiles and leather," Oswald said.
Broader Implications for the Textile and Leather Value Chain
The global textile industry is currently responsible for approximately 10% of global carbon emissions and 20% of industrial water pollution worldwide. As the European Union moves forward with the "Strategy for Sustainable and Circular Textiles" and the "Ecodesign for Sustainable Products Regulation" (ESPR), manufacturers are facing a "compliance cliff." These regulations will soon require digital product passports and strict limits on chemical residues.
By aligning with bluesign, Novonesis provides its clients—the textile mills and tanneries—with a "safe harbor" of chemical inputs. When a mill uses bluesign-approved enzymes from Novonesis, it simplifies its own certification process, making it more attractive to major fashion brands like Nike, Patagonia, and Adidas, all of whom utilize the bluesign system to manage their supply chain risks.
In the leather sector, the implications are equally profound. Leather processing has historically been associated with high levels of chromium and sulfide waste. Novonesis’ enzymatic solutions for dehairing and bating (softening) the hides allow tanneries to reduce their sulfide load by up to 40%. This not only makes the wastewater easier to treat but also improves the quality and yield of the leather, demonstrating that sustainability and profitability can coexist.
Market Analysis and Future Outlook
The market for bio-based chemicals in the textile industry is projected to grow at a compound annual growth rate (CAGR) of over 8% through 2030. This growth is driven by a combination of regulatory pressure and a shift in consumer sentiment. A 2025 consumer survey indicated that 64% of global fashion consumers are willing to pay a premium for garments that are certified as "toxin-free" or "eco-friendly."
The partnership between Novonesis and bluesign is likely to catalyze further innovation in the "wet processing" stage of textile manufacturing—the stage where the highest volume of chemicals and water is used. Looking ahead, Novonesis is expected to expand its bluesign-certified offerings to include bio-based dyes, finishing agents, and specialized enzymes for recycled fiber processing.
As the industry moves toward a circular economy, the ability to process recycled textiles without damaging the fibers is crucial. Enzymes offer a precision that mechanical or harsh chemical processes cannot match, allowing for the selective removal of dyes or coatings from blended fabrics. The bluesign partnership ensures that these next-generation circular solutions will be developed with the highest safety standards from the outset.
The integration of Novonesis into the bluesign System marks a new chapter in industrial bioprocessing. It bridges the gap between high-level laboratory science and the practical, day-to-day realities of global manufacturing. For the textile and leather industries, it offers a clear pathway to decarbonization and chemical safety, proving that the future of fashion may very well be written in the language of biology.
